These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24342765)

  • 1. The debated role for thiopurines in Crohn's disease.
    Herrlinger KR; Stange EF
    J Crohns Colitis; 2014 Feb; 8(2):172-4. PubMed ID: 24342765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective.
    Axelrad JE; Roy A; Lawlor G; Korelitz B; Lichtiger S
    World J Gastroenterol; 2016 Dec; 22(46):10103-10117. PubMed ID: 28028358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of thiopurine agents in ulcerative colitis].
    Chaparro M; Gisbert JP
    Gastroenterol Hepatol; 2011 Dec; 34 Suppl 3():30-5. PubMed ID: 25443224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-Mercaptopurine/Azathioprine remains an important contributor in managing Crohn's disease.
    Korelitz BI; Present DH
    J Crohns Colitis; 2014 Aug; 8(8):735-8. PubMed ID: 24462321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Crohn's disease: no advantage by azathioprine and 6-mercaptopurine].
    Schreiber S
    Dtsch Med Wochenschr; 2013 Sep; 138(38):1877. PubMed ID: 24022448
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic efficacy and safety of 6-mercaptopurine and azathioprine in patients with Crohn's disease.
    Markowitz JF
    Rev Gastroenterol Disord; 2003; 3 Suppl 1():S23-9. PubMed ID: 12684586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunosuppressive treatment of Crohn's disease].
    Kasper H; Auer I
    Dtsch Z Verdau Stoffwechselkr; 1976; 36(3-4):143-5. PubMed ID: 1021382
    [No Abstract]   [Full Text] [Related]  

  • 8. Thiopurines in Crohn's disease, is there something new?
    Miheller P; Lakatos PL
    Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1505-14. PubMed ID: 20919963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.
    Terdiman JP; Gruss CB; Heidelbaugh JJ; Sultan S; Falck-Ytter YT;
    Gastroenterology; 2013 Dec; 145(6):1459-63. PubMed ID: 24267474
    [No Abstract]   [Full Text] [Related]  

  • 10. 6-Mercaptopurine and other immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.
    Present DH
    Gastroenterol Clin North Am; 1989 Mar; 18(1):57-71. PubMed ID: 2646222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressants and Crohn's disease.
    Goldstein F
    Gastroenterology; 1972 May; 62(5):1101-2. PubMed ID: 5029074
    [No Abstract]   [Full Text] [Related]  

  • 12. Is thiopurine therapy in ulcerative colitis as effective as in Crohn's disease?
    Ghosh S; Chaudhary R; Carpani M; Playford RJ
    Gut; 2006 Jan; 55(1):6-8. PubMed ID: 16344570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis.
    Peyrin-Biroulet L; Deltenre P; Ardizzone S; D'Haens G; Hanauer SB; Herfarth H; Lémann M; Colombel JF
    Am J Gastroenterol; 2009 Aug; 104(8):2089-96. PubMed ID: 19568226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunosuppressive treatment and Crohn's disease].
    Delwaide J; Louis E; Gast P; Belaiche J
    Rev Med Liege; 1991 Jan; 46(1):22-8. PubMed ID: 2011678
    [No Abstract]   [Full Text] [Related]  

  • 15. [When is drug therapy with azathioprine indicated in Crohn's disease?].
    Rogler G; Herfarth H
    Dtsch Med Wochenschr; 2002 May; 127(22):1213-4. PubMed ID: 12035120
    [No Abstract]   [Full Text] [Related]  

  • 16. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Mercaptopurine Usage despite Azathioprine-Induced Pancreatitis in Paediatric Crohn's Disease.
    Gallego-Gutiérrez S; Navas-López VM; Kolorz M; Bartosova L; Lukac K; Luque-Pérez S; Núñez-Caro L; García-Galán P; Fernández-Crehuet FG; Blasco-Alonso J; Serrano-Nieto MJ; Sierra-Salinas C
    J Crohns Colitis; 2015 Aug; 9(8):676-9. PubMed ID: 25968582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.
    Dassopoulos T; Sultan S; Falck-Ytter YT; Inadomi JM; Hanauer SB
    Gastroenterology; 2013 Dec; 145(6):1464-78.e1-5. PubMed ID: 24267475
    [No Abstract]   [Full Text] [Related]  

  • 19. Azathioprine and 6 Mercaptopurine in postoperative maintenance of Crohn's disease remission: is no evidence of effect an evidence of no effect?
    Mardini HE
    Gastroenterology; 2005 Jan; 128(1):246-8; author reply 248-9. PubMed ID: 15633153
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
    Kim PS; Zlatanic J; Korelitz BI; Gleim GW
    Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.